Printer Friendly

TSI CORPORATION FILES REGISTRATION STATEMENT WITH SEC FOR PUBLIC OFFERING OF 2,300,000 SHARES OF COMMON STOCK

 TSI CORPORATION FILES REGISTRATION STATEMENT WITH SEC
 FOR PUBLIC OFFERING OF 2,300,000 SHARES OF COMMON STOCK
 WORCESTER, Mass., Dec. 24 /PRNewswire/ -- TSI Corporation (NASDAQ: TSIN) today announced that it filed a registration statement with the Securities and Exchange Commission relating to a proposed public offering of 2,300,000 shares of the company's common stock, 2 million of which will be sold by the company and 300,000 of which will be sold by selling security holders other than executive officers and directors of the company. The offering contemplates that the company will grant the underwriters an option to purchase up to 345,000 additional shares to cover overallotments.
 Cowen & Company and Montgomery Securities are the managing underwriters for the offering. Proceeds to the company are expected to be used for general purposes. The company will receive none of the proceeds from the sale of common stock by the selling shareholders.
 The public offering price is expected to be based upon the prevailing market price of the company's shares at the time of the public sale. A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there by any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
 A copy of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933 may be obtained from Cowen & Company, One Financial Square, New York, NY 10005; or Montgomery Securities, Prospectus Department, 600 Montgomery Street, 21st Floor, San Francisco, Calif., 94111.
 TSI is a life sciences company offering in vivo preclinical and toxicology testing services, human clinical and in vitro testing services, and diagnostic intermediate products. TSI is also developing advanced toxicology tests and disease models based on genetic engineering and transgenic techniques to improve the efficiency of the pharmaceutical/chemical development process.
 -0- 12/24/91
 /CONTACT: James P. Sherblom, chairman and CEO of TSI Corp., 508-755-0550; or Robert Gottlieb, vice president of Feinstein Partners, 617-577-8110, for TSI/
 (TSIN) CO: TSI Corporation ST: Massachusetts IN: MTC SU: OFR


DH -- NE002 -- 5114 12/24/91 09:29 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 24, 1991
Words:416
Previous Article:HALIFAX CORPORATION ANNOUNCES SALE OF HALIFAX SECURITY SERVICES
Next Article:EPE ANNOUNCES CONTINUATION OF ITS COMPREHENSIVE FINANCIAL RESTRUCTURING NEGOTIATIONS
Topics:


Related Articles
TSI ANNOUNCES FINANCING INTENTION, CONVERTIBILITY OF PREFERRED STOCK
PROTEIN DESIGN LABS INC. FILES REGISTRATION STATEMENT WITH SEC
COLTEC INDUSTRIES FILES INITIAL PUBLIC OFFERING
BIOSYS FILES FOR INITIAL PUBLIC OFFERING OF COMMON STOCK
TSI SHELF REGISTRATION STATEMENT FOR WARRANTS TO PURCHASE COMMON STOCK AND COMMON STOCK FOR SECURITYHOLDERS DECLARED EFFECTIVE BY SEC
ROBERTS PHARMACEUTICAL CORPORATION FILES PROPOSED OFFERING OF COMMON STOCK WITH SEC
AVIGEN, INC. FILES INITIAL PUBLIC OFFERING REGISTRATION STATEMENT
TARGETED GENETICS FILES REGISTRATION STATEMENT FOR PUBLIC OFFERING OF 3,500,000 SHARES OF COMMON STOCK
Digene Corporation Announces Closing of Over-Allotment Option Exercise by Underwriters.
Roper Industries Prices Public Offering of 2.3 Million Shares of Common Stock in Conjunction with Inclusion in the S&P 500(R).

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters